Arshad is a founder of Zaylan Associates, a strategy consulting practice specializing in digital innovation in life sciences and healthcare. Zaylan is a close partner of Chrysalis, jointly engaging on projects in digital innovation and precision medicine. Arshad’s experience in digital transformation spans early research, translational, clinical trials, medical affairs, commercial and patient/physician engagement. Arshad started his career as an Analyst with Boston Consulting Group, thirty years ago. He served as the Vice President of Strategy and Business Development at Danaher where he and his team developed the strategy and business case for transformative acquisitions such as Pall Corporation which enabled Danaher’s entry into Bioprocessing. Prior to Danaher, Arshad was the founding Partner of Scientia Advisors management consulting (now Precision for Medicine) focused on life sciences and healthcare strategy. Over the years, he has advised large companies in Pharmaceuticals, Life Sciences Tools, Diagnostics, Medtech, and Digital Health Informatics sectors, including but not limited to Danaher, Novartis, Philips, Avantor, iNDX.ai and numerous other companies. Arshad holds a BS in Electrical Engineering and Computer Science from the University of Illinois and an MBA in Finance and Business Strategy from the University of Chicago.